A61K 35/15
Cells of the myeloid line
Official title: Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells (presenting a specific antigen A61K39/00; therapeutic combinations of antibodies, or fragments thereof, and blood-derived cells A61K39/00)
A61K35/15 (Cells of the myeloid line) appears on 389 US grants and 923 published applications in this corpus.
Search patents in A61K- Granted patents
- 389
- Published applications
- 923
- Assignees
- 534
- Inventors
- 1,868
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 5 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 6 |
| 2003 | 3 | 3 |
| 2004 | 1 | 9 |
| 2005 | 3 | 7 |
| 2006 | 2 | 8 |
| 2007 | 2 | 9 |
| 2008 | 4 | 14 |
| 2009 | 1 | 7 |
| 2010 | 4 | 10 |
| 2011 | 3 | 5 |
| 2012 | 2 | 26 |
| 2013 | 11 | 19 |
| 2014 | 11 | 22 |
| 2015 | 14 | 36 |
| 2016 | 7 | 39 |
| 2017 | 19 | 47 |
| 2018 | 20 | 48 |
| 2019 | 30 | 66 |
| 2020 | 29 | 60 |
| 2021 | 27 | 65 |
| 2022 | 36 | 87 |
| 2023 | 27 | 70 |
| 2024 | 38 | 86 |
| 2025 | 29 | 87 |
| 2026 | 33 | 87 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for treating pancreatic cancer and other solid tumors6 Oct 2026US 12,751,991 B2Lisata Therapeutics, Inc.
- FATS as a target for treating tumors and uses thereof6 Oct 2026US 12,753,410 B2Tianjin Medical University
- Systems and methods for returning treated mononuclear cells to a blood source29 Sep 2026US 12,746,317 B2Fenwal, Inc.
- FOXM1-derived peptide, and vaccine including same29 Sep 2026US 12,747,265 B2Oncotherapy Science, Inc.
- Pharmaceutical composition for treating amyotrophic lateral sclerosis25 Aug 2026US 12,714,727 B2Nipro Corporation
- Application of CCR5hi Innate Immune Memory Cells in Preparation of Immunotherapeutic Drug for Treating Sepsis8 Oct 2026US 2026/0306538 A1Children's Hospital of Soochow University
- Xenogeneic antigen presenting cells and uses thereof8 Oct 2026US 2026/0306539 A1
- Antigen-specific physiologic dendritic cells for therapy8 Oct 2026US 2026/0306597 A1Emory University
- Methods of sensitizing tumors to treatment with immune checkpoint inhibitors8 Oct 2026US 2026/0306658 A1University of Florida Research Foundation, Inc.
- Compositions comprising and methods of using dendritic cell exosomes8 Oct 2026US 2026/0308524 A1Baylor College of Medicine
Most cited
By later US patents
- Platelet glue wound sealant215US 5,733,545 AQuantic Biomedical Partners · 1998
- Composition and method for the repair and regeneration of cartilage and other tissues193US 7,148,209 B2Ecole Polytechnique · 2006
- Monoclonal antibodies to FC receptors for immunoglobulin G on human mononuclear phagocytes92US 4,954,617 ATrustees of Dartmouth College · 1990
- Method for preparing membrane vesicles67US 6,899,863 B1Anosys, Inc., Institute Curie · 2005
- Method for isolating dendritic cells64US 5,643,786 AThe United States of America as represented by the Department of Health and Human Services · 1997